
CASE REPORT OF A NOVEL MUTATION OF THE EYA1 GENE
IN A PATIENT WITH BRANCHIO-OTO-RENAL SYNDROME Spahiu L, Merovci B, Ismaili Jaha V, Batalli Këpuska A, Jashari H *Corresponding Author: Dr. Besart Merovci, Pediatric Clinic, University Clinical Center of Kosovo, Pristina, Republic
of Kosovo. Tel: +377-44-161-538. E-mail: m_besart@hotmail.com page: 91
|
DISCUSSION
The incidence of BOR is estimated between 1:40,000
to 1:700,000. However, the incidence is higher among
deaf children [2]. Fraser et al. [3] reported that 2.0% of
deaf patients and 6.0% of ESRD patients have genetically
proven BOR syndrome. Furthermore, more than 80
disorders presenting with sensorineural deafness and renal
disturbances have been reported. Thus, phenotypic criteria
should often be complemented with genetic analysis to
avoid misdiagnosis.
Major phenotypic anomalies that occur in more than
20.0% of patients are: sensorineural or mixed hearing
impairment (95.4%), followed by malformed auricles
(86.8%), second branchial arch fistula/cyst (86.5%), preauricular
sinus (87.0%), and renal anomalies ranging from
mild hypoplasia to complete absence (58.3%) [4]. In addition,
phenotypic anomalies occurring in less than 20.0%
of patients are considered minor, i.e., pre-auricular tags,
lacrimal duct aplasia, retrognathia, short palate, palatoschisis,
facial paralysis, meatal atresia, etc. Likewise, at least
three major criteria or two major and two minor criteria
or one major criteria plus an affected first degree relative
must be fulfilled to meet the clinical criteria for a BOR
syndrome diagnosis [5]. Branchial fistulae, pre-auricular
tags and conductive hearing impairment were present in
all three members of the presented family. Also, renal abnormalities
in the form of unilateral hypoplasia (father and
sister) and bilateral hypoplasia (our patient) corresponding
with BOR syndrome diagnosis were confirmed. However,
variable phenotypic expressivity within families due to
reduced penetrance has been observed [6]. Pierides et al.
[1] followed 20 members of a three-generation Greek-
Cypriot family for nearly three decades, and found only
four members manifesting with all four BOR syndrome
features of brachial fistulae, hearing loss, pre-auricular pits
and renal abnormalities leading to renal failure.
In 1992, the BOR gene was mapped to chromosome
8q12-22 [7]. Five years later, the BOR gene was identified
as the human homologue of the Drosophila eyes absent
gene (eya) and called it EYA1 [8]. However, mutations and
deletions of the EYE1 gene have been identified in only
about 40.0% of individuals with the BOR phenotype. Mutations
of other genes such as SIX1 and SIX5 have also been
related to BOR syndrome, but at a much lower incidence
[9-11]. At least 80 mutations of the EYE1 gene resulting in
BOR syndrome [12], suggests that the type of mutation has
a dosage effect, explaining the variable ex-pressivity within
families. Further studies are needed to better understand the
phenotypical expressivity of BOR syndrome.
Branchial anomalies account for up to 45.0% of neck
pathologies. It is usually the main complaint that families
seek medical attention for [13]. Hence, BOR syndrome
should always be considered in patients with branchial
fistula and/or external ear anomalies or similar findings
in other family members.
Declaration of Interest. The authors report no conflicts
of interest. The authors alone are responsible for the
content and writing of this article.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|